Tekla Life Sciences Investors (NYSE:HQL) Shares Bought by Wedbush Securities Inc.

Posted by on Apr 19th, 2023

Wedbush Securities Inc. lifted its stake in shares of Tekla Life Sciences Investors (NYSE:HQL – Get Rating) by 17.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 16,762 shares of the company’s stock after purchasing an additional 2,450 shares during the period. Wedbush Securities Inc. owned about 0.07% of Tekla Life Sciences Investors worth $238,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of HQL. IHT Wealth Management LLC acquired a new stake in Tekla Life Sciences Investors during the first quarter valued at approximately $170,000. Eudaimonia Partners LLC acquired a new position in Tekla Life Sciences Investors in the first quarter worth $199,000. Raymond James Trust N.A. bought a new stake in Tekla Life Sciences Investors during the third quarter valued at $166,000. Nations Financial Group Inc. IA ADV raised its holdings in shares of Tekla Life Sciences Investors by 18.8% during the third quarter. Nations Financial Group Inc. IA ADV now owns 13,900 shares of the company’s stock worth $190,000 after purchasing an additional 2,200 shares during the period. Finally, Cambridge Investment Research Advisors Inc. lifted its position in shares of Tekla Life Sciences Investors by 15.3% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 14,930 shares of the company’s stock worth $247,000 after buying an additional 1,982 shares during the last quarter. Institutional investors own 15.95% of the company’s stock.

Tekla Life Sciences Investors Stock Down 0.6 %

Shares of NYSE:HQL opened at $14.09 on Wednesday. The firm has a 50-day simple moving average of $14.03 and a 200 day simple moving average of $14.36. Tekla Life Sciences Investors has a fifty-two week low of $13.03 and a fifty-two week high of $17.12.

Tekla Life Sciences Investors Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 31st. Stockholders of record on Monday, February 27th were given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 9.37%. This is a boost from Tekla Life Sciences Investors’s previous quarterly dividend of $0.31. The ex-dividend date was Friday, February 24th.

Tekla Life Sciences Investors Profile

(Get Rating)

Tekla Life Sciences Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

Featured Articles

Want to see what other hedge funds are holding HQL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tekla Life Sciences Investors (NYSE:HQL – Get Rating).

Institutional Ownership by Quarter for Tekla Life Sciences Investors (NYSE:HQL)

Receive News & Ratings for Tekla Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.